Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 5/20 | 0.39 |
| ▸ | CA9 | Q16790 | 5/20 | 0.39 |
| ▸ | CA2 | P00918 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 4/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.39 |
| ▸ | CA7 | P43166 | 2/20 | 0.39 |
| ▸ | CA5A | P35218 | 2/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | FASN | P49327 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.33 |
| ▸ | NQO1 | P15559 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | BCR | P11274 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14327172 | 0.94 | BACE1 (0.41) | BACE1CA12CA9CA2CA1 | |
| SCHEMBL14088881 | 0.82 | HCAR1 (0.45) | BACE1ALDH1A1HSD17B10CYP3A4HPGD | |
| SCHEMBL20736714 | 0.82 | BACE1 (0.32) | BACE1 | |
| SCHEMBL13806490 | 0.82 | ALDH1A1 (0.36) | BACE1CA12CA9CA2CA1 | |
| SCHEMBL28234290 | 0.82 | ALDH1A1 (0.55) | BACE1ACHEALDH1A1HSD17B10CYP3A4 | |
| SCHEMBL24933931 | 0.77 | NQO1 (0.54) | NQO1 | |
| SCHEMBL19826377 | 0.77 | ACHE (0.34) | ACHE | |
| SCHEMBL19884769 | 0.77 | PTGS2 (0.36) | CA12CA9CA2CA1CA14 | |
| SCHEMBL27360772 | 0.77 | NQO1 (0.60) | ALDH1A1HSD17B10FASNCYP3A4LMNA | |
| SCHEMBL17366351 | 0.75 | ALDH1A1 (0.36) | ALDH1A1HSD17B10CYP3A4LMNAHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200299671-A1 | IMMOBILIZED MULTI-ENZYMATIC HALOGENATION SYSTEM | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2020-09-24 | — | — | US | disclosed |
| EP-3653735-A1 | REPTILE SKIN PRODUCT AND PRODUCTION METHOD FOR REPTILE SKIN PRODUCT | Citizen Watch Co., Ltd. (JP) | 2020-05-20 | — | — | EP | disclosed |
| EP-3401732-B1 | HIGH RESOLUTION FLEXOGRAPHIC PRINTING PLATE AND MEANS FOR CONSTRUCTING SAME | FOLEX AG (CH) | 2020-02-05 | — | — | EP | disclosed |
| EP-2960333-B1 | COMPOSITION FOR INHIBITING GENE EXPRESSION AND USES THEREOF | IDERA PHARMACEUTICALS INC (US) | 2017-10-04 | — | — | EP | disclosed |
| US-9012572-B2 | Polyphenylene ether oligomer and article employing the same | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2015-04-21 | — | — | US | disclosed |
| US-20140323666-A1 | POLYPHENYLENE ETHER OLIGOMER AND ARTICLE EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2014-10-30 | — | — | US | disclosed |
| US-20100152081-A1 | Fluorosurfactants | MERCK PATENT GMBH (DE) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152081-A1 | Fluorosurfactants | CBR3, FPR3, NOX3 | BACE1 3681/4885CA12 455/4885CA9 501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.